Literature DB >> 10219240

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress.

H Hirota1, J Chen, U A Betz, K Rajewsky, Y Gu, J Ross, W Müller, K R Chien.   

Abstract

Biomechanical stress is a major stimulus for cardiac hypertrophy and the transition to heart failure. By generating mice that harbor a ventricular restricted knockout of the gp130 cytokine receptor via Cre-IoxP-mediated recombination, we demonstrate a critical role for a gp130-dependent myocyte survival pathway in the transition to heart failure. Such conditional mutant mice have normal cardiac structure and function, but during aortic pressure overload, these mice display rapid onset of dilated cardiomyopathy and massive induction of myocyte apoptosis versus the control mice that exhibit compensatory hypertrophy. Thus, cardiac myocyte apoptosis is a critical point in the transition between compensatory cardiac hypertrophy and heart failure. gp130-dependent cytokines may represent a novel therapeutic strategy for preventing in vivo heart failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219240     DOI: 10.1016/s0092-8674(00)80729-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  156 in total

Review 1.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

Review 2.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

3.  Involvement of a small GTP-binding protein (G protein) regulator, small G protein GDP dissociation stimulator, in antiapoptotic cell survival signaling.

Authors:  A Takakura; J Miyoshi; H Ishizaki; M Tanaka; A Togawa; Y Nishizawa; H Yoshida; S i Nishikawa; Y Takai
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

Review 4.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 5.  Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.

Authors:  K R Chien
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 6.  Interleukin 6 and liver regeneration.

Authors:  K L Streetz; T Luedde; M P Manns; C Trautwein
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

7.  Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.

Authors:  N H Purcell; G Tang; C Yu; F Mercurio; J A DiDonato; A Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

8.  Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community.

Authors:  D J Hetmanski; N J Sparrow; S Curtis; A J Cowley
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

9.  Increased formation of F(2)-isoprostanes in patients with severe heart failure.

Authors:  J L Cracowski; F Tremel; C Marpeau; J P Baguet; F Stanke-Labesque; J M Mallion; G Bessard
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

10.  Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.

Authors:  D Skudicky; K Sliwa; A Bergemann; G Candy; P Sareli
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.